ICUI

ICU Medical, Inc. Healthcare - Medical Instruments & Supplies Investor Relations →

YES
0.3% BELOW
↓ Approaching Was 0.9% last week
-15% -10% -5% 0% 5% 10% 15%+
Buy Threshold $140.84
14-Week RSI 62
Rel. Volume (14w) This week's trading vs. the 14-week average 1.2x
Buyers vs. Sellers (14w) Are up-weeks or down-weeks getting more volume? 0.97

ICU Medical, Inc. (ICUI) closed at $140.37 as of 2026-06-19, trading 0.3% below its 200-week moving average of $140.84. This places ICUI in the below line zone. The stock is currently moving closer to the line, down from 0.9% last week. The 14-week RSI sits at 62, indicating neutral momentum.

Trading volume is running at 1.2x of its 14-week average, which is in the normal range. The balance between buying and selling volume (0.97 ratio) is neutral — neither side is clearly dominating.

Over the past 1737 weeks of data, ICUI has crossed below its 200-week moving average 27 times. On average, these episodes lasted 21 weeks. Historically, investors who bought ICUI at the start of these episodes saw an average one-year return of +6.2%.

With a market cap of $3.5 billion, ICUI is a mid-cap stock. The company generates a free cash flow yield of 11.0%, which is notably high. Return on equity stands at 2.3%. The stock trades at 1.7x book value.

Share count has increased 2.9% over three years, indicating dilution.

Over the past 33.3 years, a hypothetical investment of $100 in ICUI would have grown to $1296, compared to $3011 for the S&P 500. ICUI has returned 8.0% annualized vs 10.8% for the index, underperforming the broader market over this period.

In the past 12 months, corporate insiders have made 2 open-market purchases totaling $2,626,073. Notably, these purchases occurred while ICUI is trading below its 200-week moving average — insiders are buying when the market is most pessimistic.

Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.

Business Health

Annual financials — how the underlying business has performed over the past several years.

Cash Flow Free cash flow & net income ($M)

Revenue Annual revenue ($M) — business growth proxy

Total Debt Balance sheet debt ($M)

ROIC Return on invested capital (%)

FCF Yield Free cash flow / market cap (%) — Yartseva signal

Gross Margin Pricing power & competitive moat (%)

Shares Outstanding Buybacks vs dilution (millions)

Growth of $100: ICUI vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After ICUI Crosses Below the Line?

Across 27 historical episodes, buying ICUI when it crossed below its 200-week moving average produced an average return of +6.6% after 12 months (median +4.0%), compared to +12.6% for the S&P 500 over the same periods. 60% of those episodes were profitable after one year. After 24 months, the average return was +22.0% vs +26.8% for the index.

Each line shows $100 invested at the moment ICUI crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Bean Score Experimental

The Bean Score measures how far a stock's free cash flow yield has deviated from its own quarterly baseline, normalized by the stock's historical behavior. Between earnings dates, FCF is constant — so the score is purely a function of stock price. The levels below show at what prices ICUI would reach each dislocation threshold.

Current Bean Score -0.94σ
Current FCF Yield 2.17%
Baseline Yield 2.40%
Historical σ 0.19pp

Dislocation Price Levels

Prices where ICUI's Bean Score would hit each σ threshold. Valid until next earnings report: 2026-08-06.

LevelσPriceSignal
Deep Value+2σ$108.69Unusually cheap — potential buy zone
Value+1σ$116.82Cheap vs. own history
Fair Value+0σ$126.27Historical mean behavior
Expensive-1σ$137.38Expensive vs. own history
Deep Expensive-2σ$150.64Unusually expensive — potential trim zone

Quarterly FCF & Yield Trailing twelve-month free cash flow and yield at each quarter end

Data depth: 2 quarterly baselines, 22 price observations — Limited history (4+ quarters preferred for reliability)

Signal Accuracy Collecting Data

The Bean Score system is accumulating weekly data to validate signal accuracy. After 13+ weeks of history, this section will display win rates and average returns for each σ threshold crossing — answering the question: "When this score says cheap or expensive, does the price subsequently move in the expected direction?"

11 / 13 weeks minimum

Theoretical framework — not backtested or forward-tested. The Bean Score uses trailing twelve-month free cash flow yield as a dislocation identifier. It measures whether the market has pushed a stock's yield unusually far from its own baseline behavior. These levels are reference points for identifying potential swing trade opportunities, not buy/sell signals. FCF values update quarterly with earnings; between reports, all movement is price-driven.

Dislocation Scores Experimental

Each score measures deviation from ICUI's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.

Yield Dislocation N/A Dividend yield vs own 10-yr norm
Drawdown Score +0.59σ Distance from line vs own history
Sector-Relative -0.48σ Vs sector median this week
Buyback Acceleration -0.3pp YoY share change vs own 3-yr pace (− = accelerating)
Insider Intensity 79th TTM buys / market cap, percentile of buyers
FCF Yield vs History +9.9pp Vs own recent annual mean
Earnings Quality Stable Accrual gap trend (-0.2pp of revenue)

Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. They are starting points for research, not buy or sell signals. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.

Advertisement

Insider Buying Activity

1 conviction buy in the past 12 months (purchases over $500K with meaningful position increases).

DateInsiderTitleValueSharesPosition +%
2025-08-14JAIN VIVEKChief Executive Officer$2,474,37521,929+8.5%

Historical Touches

ICUI has crossed below its 200-week MA 27 times with an average 1-year return of +6.2% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
Jul 1994Oct 1994138.6%+35.6%+1771.6%
Oct 1995Dec 199596.8%-36.2%+1618.8%
Jul 1996Dec 19977748.5%-33.7%+1730.9%
Aug 1998Sep 199847.1%+10.9%+1567.8%
Oct 1999Oct 1999311.5%+108.1%+1601.5%
Jul 2003Aug 200332.7%+12.3%+484.9%
Oct 2003Oct 200311.5%N/A+453.7%
Jul 2004Feb 20053326.1%+19.5%+420.9%
Jun 2005Jun 200532.6%+31.1%+359.9%
Aug 2005Oct 20051111.3%+34.9%+366.2%
Jul 2007Aug 200726.9%-12.8%+320.0%
Dec 2007Jan 200811.0%-6.2%+298.9%
Jan 2008Apr 20096535.4%+4.8%+382.4%
May 2009May 200911.0%-8.7%+298.6%
Aug 2009Aug 200910.0%-4.6%+288.1%
Sep 2009Dec 2009137.3%+2.9%+289.4%
Jan 2010Jul 20102511.8%+12.6%+303.6%
Aug 2010Aug 201011.5%+16.1%+307.0%
Aug 2019Feb 20202619.1%+6.5%-15.9%
Feb 2020Mar 2020513.3%+6.0%-28.3%
May 2020Dec 20203416.1%+0.8%-29.1%
Jan 2021Sep 20213214.0%+1.6%-31.4%
Jan 2022Feb 202235.1%-11.2%-33.3%
Apr 2022Sep 202412556.6%-15.4%-34.4%
Nov 2024Jan 20266028.4%-18.7%-16.4%
Feb 2026Feb 202610.1%N/A-3.1%
Mar 2026Ongoing16+16.4%Ongoing+6.3%
Average21+6.2%

Frequently Asked Questions

Is ICUI below its 200-week moving average?

Yes. As of 2026-06-19, ICU Medical, Inc. (ICUI) is trading 0.3% below its 200-week moving average of $140.84. The current price is $140.37.

What is ICUI's 200-week moving average price?

ICU Medical, Inc.'s 200-week moving average is $140.84 as of 2026-06-19. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.

What happens when ICUI drops below its 200-week moving average?

ICUI has crossed below its 200-week moving average 27 times in our data. On average, buying at that moment produced a one-year return of +6.2%. These dips have historically been decent entry points. These episodes lasted 21 weeks on average.

Is ICUI a good value right now?

Here's what our data says about ICUI as of 2026-06-19: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 62. Free cash flow yield is 11.0%. Return on equity is 2.3%. Price-to-book is 1.7x. This is not a buy or sell recommendation — always do your own research.

How does ICUI compare to the S&P 500?

Over the past 33.3 years, $100 invested in ICUI would have grown to $1296, compared to $3011 for the S&P 500. That's 8.0% annualized vs 10.8% for the index. ICUI has underperformed the broader market over this period.

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of week of 2026-06-19